05/07/2021 The beginning of clofoctol story in covid19 Partagez cet article You will read why we decided to run clinical trials with clofoctol in covid19… Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology | bioRxiv Previous articleHERE WE ARE, THE CLOFOCTOL TRIAL IN COVID19 WILL BEGIN!Next article 15th edition of the Rare Disease Day